Ameliorating Effect of f Piperine on NO-cGMP Pathway in Stress Induced Depression

Authors

  • Harshita Jain Chouksey Engineering College
  • Prateek Jain ADINA Institute of Pharmaceutical Sciences
  • Bharti Ahirwar Guru Ghasidas Central University University
  • Dheeraj Ahirwar Chouksey Engineering College

Keywords:

Depression, Piperine, Nitric oxide

Abstract

Depression has become a common illness among individuals of every age group. Among numerous factors held responsible for depression stress is most vital. Behind the specified disorder various hypothesis has been laid out where Nitric Oxide is emerging target to treat stress induced depression. Antidepressant potential of piperine in stressed and unstressed condition was evaluated using tail suspension test and forced swim test whereas locomotor activity was evaluated by actophotometer. Results of the present study indicate the potential of antidepressant effect of piperine in stress. Methylene blue potentiated the effect of sub- effective dose of PP and SB-203580 enhanced effect of Piperine in stressed mice with no array on locomotor activity with direct influence on Nitric oxide. Piperine produced significant changes in Nitric oxide level which is pathophysiologic mediator(s) of depression, which validate the action of piperine on depression symptoms.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Harshita Jain, Chouksey Engineering College

School of Pharmacy, Chouksey Engineering College, Bilaspur
Bilaspur- 495004,
495004 C.G, India

Prateek Jain, ADINA Institute of Pharmaceutical Sciences

ADINA Institute of Pharmaceutical Sciences, Sagar
Sagar-470002, Madhya Pradesh,
radesh, India

Bharti Ahirwar, Guru Ghasidas Central University University

Department of Pharmacy, Guru Ghasidas Central University
University, Bilaspur- 495004,
495004 C.G, India

Dheeraj Ahirwar, Chouksey Engineering College

School of Pharmacy, Chouksey Engineering College, Bilaspur
Bilaspur- 495004,
495004 C.G, India

References

André, M., Latado, H., Felley-Bosco, E. (2005). Inducible nitric oxide synthase-dependent stimulation of PKGI and phosphorylation of VASP in human embryonic kidney cells. Biochemical Pharmacology 69:595–602.

Baranano, D.E., Ferris, C.D., Snyder, S.H. (2001). A typical neural messengers. Trends in Neurosciences 24: 99-106.

Bhattacharya, S.K., Bhattacharyya D. (1982). Effect of restraint stress on rat brain serotonin Journal of Biosciences 4: 269.

Bhutani, M.K., Bishnoi, M., Kulkarni, S.K (2008). Anti- depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacology Biochemistry and Behavior 92(1): 39-43.

Paola De Cesaris, Donatella Starace, Giuseppe Starace, Antonio Filippini, Mario Stefanini, and Elio Ziparo. (1999). Activation of Jun N-terminal Kinase/Stress-activated ProteinKinase Pathway by Tumor Necrosis Factor a Leads to Intercellular Adhesion Molecule-1 Expression. Journal of Biological Chemistry 274(41): 28978-28982.

Da Silva, G.D., Matteussi, A.S., dos Santos, A.R., Calixto, J.B., Rodrigues, A.L. (2000). Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuroreport 11: 3699-3702.

De Oliveira, R.M., Del Bel, E.A., Mamede-Rosa, M.L., Padovan, C.M., Deakin, J.F., Guimarães, F.S. (2000). Expression of neuronal nitric oxide synthase mRNA in stress-related brain areasvafter restraint in rats. Neuroscience Letters 289:123-126.

De Oliveira, R.M.W., Guimarães, F.S., Deakin, J.F.W. (2008). Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Brazilian Journal of Medical and Biological Research 41(4):333– 341.

Douma, S.L., Husband, C., O’Donnell, M.E., Barwin, B.N., Woodend, A.K. (2005). Estrogen-related Mood Disorders Reproductive Life Cycle Factors. Advances in Nursing Science 28(4): 364-375.

Dzoljic, E., De Vries, R., Dzoljic, M.R.( 1997). New and potent inhibitors of nitric oxide synthase reduce motor activity in mice. Behavioural Brain Research 87: 209-212.

Eroglu, L., Caglayan, B. (1997). Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacological Research 36: 381-385.

Esch, T., Stefano, G.B., Fricchione, G.L., Benson, H. (2002). Stress in Cardiovascular Diseases. Medical Science Monitor 8(5): 93-101.

Esch, T., Stefano, G.B., Fricchione, G.L., Benson, H. (2002). The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinology Letters 22(3):199- 208.

Finkel, M.S., Laghrissi-Thode, F., Pollock, B.G., Rong, J. (1996). Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull 32(4): 653-658.

Gilhotra, N., Dhingra, D. (2009). Involvement of NO-cGMP pathway in anti-axiety effect of aminoguanidine in stressed mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33:1502-507.

Gow, A.J., Farkouh, C.R., Munson, D.A., Posencheg, M.A., Ischiropoulos, H.(2004). Biological significance of nitric oxide-mediated protein modifications. American Journal of Physiology - Lung Cellular and Molecular Physiology 287(2): L262-268.

Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnock, J.S., Tannenbaum, S.R. (1982). Analysis of Nitrate, nitrite, and [N-15N]-labelled nitrate in biological fuids. Anals of Biochemistry 126:131-138.

Harkin, A., Bruce, K.H., Craft, B., Paul, I.A.(1999). Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Europian Journal of Pharmacology 372: 207-213.

Holscher, C. (1997). Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends in Neurosciences 20(7): 298-303.

Jefferys, D., Funder, J. (1996). Nitric oxide modulates retention of immobility in the forced swimming test in rats. Europian Journal of Pharmacology 295:131-135.

Jopek, R., Kata, M., Nowak, G. (1999). The activity of rat brain nitric oxide synthase following chronic antidepressant treatment. Acta Poloniae Pharmaceutica 56(4): 307-310.

Madrigal, J.L., Hurtado, O., Moro, M.A., Lizasoain, I., Lorenzo, P., Castrillo, A., Boscá, L., Leza, J.C. (2002). The increase in TNF-alpha levels is implicated in NF- kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 26(2):155-163.

Mutlu, O., Ulak, G., Laugeray, A., Belzung, C. (2009). Effects of neuronal and inducible NOS inhibitor 1-[2- (trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice. Pharmacology Biochemistry & Behavior 92(1): 82-87.

Nagao, K., Takenaka, S., Yamaji, R., Inui, H., Nakano, Y. (2003). Nitric oxide synthase induction, cGMP elevation, and biopterin synthesis in vascular smooth muscle cells stimulated with interleukin-1beta in hypoxia. Journal of Biochemistry 133(4): 501-505.

Nelson, R.J., Demas, G.E., Huang, P.L., Fishman, M.C.,

Dawson, V.L., Dawson, T.M,, Snyder, S.H. (1995). Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378:383–386.

Porsolt, R.D. (1979). Animal model of depression.

Biomedicine 30(3):139-40.

Schuman, E.M., Madison, D.V. (1994). Nitric oxide and synaptic function. Annual Review of Neuroscience 17:153-183.

Sevgi, S., Ozek, M., Eroglu, L (2006). L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods and Findings in Experimental and Clinical Pharmacology 28(2):95-99.

Snyder, S.H., Bredt, D.S. (1991). Nitric oxide as a neural messenger. Trends in Pharmacological Sciences 12: 125- 128.

Steru, L., Chermat, R., Thierry, B., Simon, P.( 1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85(3): 367-70.

Michel, T., Feron, O. (1997). Nitric oxide synthases: which, where, how, and why. Journal of Clinical Investigation 100(9): 2146–2152.

Tsuchiya, T., Kishimoto, J., Koyama, J., Ozawa, T. (1997). Modulatory effect of L-NAME, a specific nitric oxide synthase (NOS) inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamic-pituitary- adrenal axis. Brain Research 776(1-2): 68-74.

Wegener, G., Volke, V., Harvey, B.H., Rosenberg, R. (2003). Local, but not systemic administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Research 959:128-133.

Wiley, J.L., Cristello, A.F., Balster, R.L. (1995). Effects of site- selective NMDA receptor antagonists in an elevated plus- maze model of anxiety in mice. Europian Journal of Pharmacology 294:101-107.

Yildiz, F., Erden, B.F., Ulak, G., Utkan, T., Gacar, N. (2000). Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl) 149: 41-44.

Yildiz, F., Ulak, G., Erden, B.F., Gacar, N. (2000). Anxiolytic- like effects of 7-nitroindazole in the rat plus-maze test. Pharmacology Biochemistry and Behavior 65:199-202

Downloads

Published

30.03.2015

How to Cite

Jain, H., Jain, P., Ahirwar, B., & Ahirwar, D. (2015). Ameliorating Effect of f Piperine on NO-cGMP Pathway in Stress Induced Depression. Journal of Science, Technology and Arts Research, 4(1), 109–114. Retrieved from https://journals.wgu.edu.et/index.php/star/article/view/167

Issue

Section

Original Research

Categories

Plaudit